Joseph Verbalis
Physician · MedStar Georgetown University Hospital
Credentials: · · · ·
History
2024–Present
- 1978–1980
Endocrinology, Diabetes, and Metabolism
- 1975–1978
Internal Medicine
Research
Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia
New England Journal of Medicine · 2006 · 881 citations
Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations
The American Journal of Medicine · 2013 · First of 7 authors · Corresponding · 810 citations
c-Fos and related immediate early gene products as markers of activity in neuroendocrine systems
Review · Frontiers in Neuroendocrinology · 1993 · Last of 3 authors · 616 citations
- MK
13 papers
- RB
10 papers
- AG
8 papers
- BO
8 papers
- AS
7 papers
7 papers
7 papers
6 papers
Grants
- 2015–2026
Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS)
National Center for Advancing Translational Sciences · UL1
Contact PI · $37.8M · Georgetown University
- 2017–2023
Hyponatremia-Induced Osteoporosis and Fragility
National Institute on Aging · R01
Contact PI · $1.9M · Georgetown University
- 2010–2016
Georgetown-Howard Universities Center for Clinical and Translational Science (GHU
National Center for Advancing Translational Sciences · UL1
Contact PI · $19.3M · Georgetown University
- 2010–2015
Georgetown-Howard Universities Center for Clinical and Translational Science (GHU
National Center for Advancing Translational Sciences · KL2
Contact PI · $1.7M · Georgetown University
Clinical trials
- 2007–2009
Principal investigator · Completed · Phase 3
Otsuka Pharmaceutical Development & Commercialization, Inc.
- 2011–2012